Table 3.
Values from VAS and TTO exercises in the UK general public (n = 100)
| Health states | VAS value(N = 100) | TTO value(N = 100) |
|---|---|---|
| Controlled disease | ||
| Mean (SD) | 71.4 (17.9) | 0.89 (0.11) |
| Min - Max | 10.0–98.0 | 0.45–1.00 |
| Intravenous treatment | ||
| Mean (SD) | 50.0 (17.8) | 0.73 (0.20) |
| Min - Max | 0.0–90.0 | 0.05–1.00 |
| Oral treatment | ||
| Mean (SD) | 71.0 (17.1) | 0.85 (0.15) |
| Min - Max | 10.0–96.0 | 0.25–1.00 |
| Oral treatment, Alternative 1 | ||
| Mean (SD) | 66.53 (17.49) | 0.82 (0.23) |
| Min - Max | 20.0–97.0 | −0.85-1.00 |
| Oral treatment, Alternative 2 | ||
| Mean (SD) | 59.1 (19.4) | 0.78 (0.18) |
| Min - Max | 10.0–94.0 | 0.15–1.00 |
SD, Standard deviation
Oral treatment, alternative 1: reduced frequency of intake and side effects
Oral treatment, alternative 2: higher frequency of intake and more frequent occurrence of side effects